Adapet Medical Inc., established in 2024, operates under the auspices of the Jointown Group. Our Pet CGM (Continuous Glucose Monitoring) project was initially launched within Jointown Group in 2022. As the project matured, Adapet Medical Inc. was founded to bring this innovative product to market.
Adapet Medical Inc. is a technology-driven enterprise committed to empowering pet owners with premium-quality products designed to enhance the health and well-being of their pets.
Our Vision and Mission
Milestone
Investment
G2M Plan
Value Proposition
Adapet A1 APP
Trial Test
Differentiators
Production Plan
Meet Our Partners
Adapet medical is honored to partner with trusted leaders in the industry. Together, we work collaboratively toimprove health outcomes for individuals with diabetes worldwide.
Recognized Partner of CVMA | Recognized Partner of AVMA
